Valeant to buy Obagi Medical for about $344 mln
March 20, 2013 at 08:12 AM EDT
March 20 (Reuters) - Canadian drugmaker Valeant Pharmaceuticals International Inc said it would buy Obagi Medical Products Inc for about $344 million to boost its dermatology and aesthetics portfolio.
